TrialCardiovascular diabetology2024

Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial.

A secondary analysis of NCT02579499. The report of the trial’s main result is not on the map, and the numbers here are shown and do not vote.

What the trial testedas reported · 2,932 people · 2024

Not counted

1.8×1.2× to 2.7×

Bigger than 8 in 10 on the map

As reported

HR 1.79, 95% CI 1.18–2.73

the abstract, start to end

… was < 70 mg/dL (13.9% versus 8.0%; HR = 1.79, 95% CI 1.18 to 2.73, …

← favours treatmentfavours comparator →

could be chance

Lipids

HR 1.791.18–2.73

StatinsLipids

1 / 3

2024

2025

2026

this paperpooled itcites it